CYP1B1 and pulmonary arterial hypertension: Given the significant increase in CYP1B1 and its product 16αOHE1 in obese male mice we assessed the effect of TMS, a selective CYP1B1 inhibitor, on the pulmonary hypertension phenotype observed in male ob/ob mice.